IL-12-polarized Th1 cells produce GM-CSF and induce EAE independent of IL-23

European Journal of Immunology

Volumn 45, Issue 10, 2015, Pages 2780-2786

  Grifka Walk, Heather M ^a,b   Giles, David A ^a,b   Segal, Benjamin M ^a,b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

Experimental autoimmune encephalomyelitis; IL 12; IL 23; Th1 cells; Th17 cells

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 23; CCR2 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CCR2; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; ANIMAL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MULTIPLE SCLEROSIS; MYELIN SHEATH; PATHOLOGY;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-23; MICE; MICE, KNOCKOUT; MULTIPLE SCLEROSIS; MYELIN SHEATH; RECEPTORS, CCR2; TH1 CELLS; TH17 CELLS;

EID: 84943199103     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201545800     Document Type: Article

References (25)

1. Ghoreschi, K., Laurence, A., Yang, X. P., Tato, C. M., McGeachy, M. J., Konkel, J. E., Ramos, H. L. et al., Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling. Nature 2010. 467: 967-971.
2. Kroenke, M. A., Carlson, T. J., Andjelkovic, A. V. and Segal, B. M., IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 2008. 205: 1535-1541.
3. Segal, B. M. and Shevach, E. M., IL-12 unmasks latent autoimmune disease in resistant mice. J. Exp. Med. 1996. 184: 771-775.
4. McGeachy, M. J., Chen, Y., Tato, C. M., Laurence, A., Joyce-Shaikh, B., Blumenschein, W. M., McClanahan, T. K. et al., The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat. Immunol. 2009. 10: 314-324.
5. Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003. 421: 744-748.
6. Haak, S., Croxford, A. L., Kreymborg, K., Heppner, F. L., Pouly, S., Becher, B. and Waisman, A., IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 2009. 119: 61-69.
7. El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G. X. et al., The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 2011. 12: 568-575.
8. Codarri, L., Gyulveszi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T. et al., RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 2011. 12: 560-567.
9. Noster, R., Riedel, R., Mashreghi, M. F., Radbruch, H., Harms, L., Haftmann, C., Chang, H. D. et al., IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells. Sci. Transl. Med. 2014. 6: 241ra280.
10. Voskuhl, R. R., Martin, R., Bergman, C., Dalal, M., Ruddle, N. H. and McFarland, H. F., T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity 1993. 15: 137-143.
11. Segal, B. M., Experimental autoimmune encephalomyelitis: cytokines, effector T cells, and antigen-presenting cells in a prototypical Th1-mediated autoimmune disease. Curr. Allergy Asthma Rep. 2003. 3: 86-93.
12. Gran, B., Zhang, G. X., Yu, S., Li, J., Chen, X. H., Ventura, E. S., Kamoun, M. et al., IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 2002. 169: 7104-7110.
13. Willenborg, D. O., Fordham, S., Bernard, C. C., Cowden, W. B. and Ramshaw, I. A., IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 1996. 157: 3223-3227.
14. Zhang, G. X., Gran, B., Yu, S., Li, J., Siglienti, I., Chen, X., Kamoun, M. et al., Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J. Immunol. 2003. 170: 2153-2160.
15. O'Connor, R. A., Prendergast, C. T., Sabatos, C. A., Lau, C. W., Leech, M. D., Wraith, D. C. and Anderton, S. M., Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 2008. 181: 3750-3754.
16. Lee, Y. K., Turner, H., Maynard, C. L., Oliver, J. R., Chen, D., Elson, C. O. and Weaver, C. T., Late developmental plasticity in the T helper 17 lineage. Immunity 2009. 30: 92-107.
17. Kurschus, F., Croxford, A., Heinen, A., Wortge, S., Ielo, D. and Waisman, A., Genetic proof for the transient nature of the Th17 phenotype. Eur. J. Immunol. 2010. 40: 3336-3346.
18. Thakker, P., Leach, M. W., Kuang, W., Benoit, S. E., Leonard, J. P. and Marusic, S., IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 2007. 178: 2589-2598.
19. Duhen, R., Glatigny, S., Arbelaez, C. A., Blair, T. C., Oukka, M. and Bettelli, E., Cutting edge: the pathogenicity of IFN-gamma-producing Th17 cells is independent of T-bet. J. Immunol. 2013. 190: 4478-4482.
20. Grifka-Walk, H. M., Lalor, S. J. and Segal, B. M., Highly polarized Th17 cells induce EAE via a T-bet independent mechanism. Eur. J. Immunol. 2013. 43: 2824-2831.
21. O'Connor, R. A., Cambrook, H., Huettner, K. and Anderton, S. M., T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease. Eur. J. Immunol. 2013. 43: 2818-2823.
22. Vass, K., Heininger, K., Schafer, B., Linington, C. and Lassmann, H., Interferon-gamma potentiates antibody-mediated demyelination in vivo. Ann. Neurol. 1992. 32: 198-206.
23. Panitch, H. S., Hirsch, R. L., Schindler, J. and Johnson, K. P., Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 1987. 37: 1097-1102.
24. Axtell, R. C., deJong, B. A., Boniface, K., van der Voort, L. F., Bhat, R., DeSarno, P., Naves, R. et al., T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 2010. 16: 406-412.
25. Segal, B. M., Dwyer, B. K. and Shevach, E. M., An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 1998. 187: 537-546.